News
A study led by Dana-Farber Cancer Institute researchers found that combining chemotherapy and immunotherapy before surgery ...
Our findings highlight the molecular diversity and diagnostic challenges of HER2-mutated NSCLC in underrepresented ...
The U.S. Food and Drug Administration (FDA) has granted accelerated approval to DATROWAY® (datopotamab deruxtecan-dlnk) for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback